BSX Boston Scientific Corp

  1. Stocks
  2. Healthcare
  3. NYSE: BSX

Price (delayed)

$53.6

Market cap

$78.48B

P/E Ratio

89.33

Dividend/share

N/A

EPS

$0.6

Enterprise value

$87.11B

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, ...

Highlights
Boston Scientific's gross profit has increased by 10% YoY and by 3.4% QoQ
The revenue has increased by 9% YoY and by 2.7% from the previous quarter
The P/E is 29% above the 5-year quarterly average of 69.3 but 4% below the last 4 quarters average of 93.1
BSX's quick ratio is down by 14% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://www.bostonscientific.com/
Peers: SYK EW TFX

Key stats

What are the main financial stats of BSX
Market
Shares outstanding
1.46B
Market cap
$78.48B
Enterprise value
$87.11B
Valuations
Price to earnings (P/E)
89.33
Price to book (P/B)
4.23
Price to sales (P/S)
5.78
EV/EBIT
49.16
EV/EBITDA
29.7
EV/Sales
6.5
Earnings
Revenue
$13.4B
EBIT
$1.77B
EBITDA
$2.93B
Free cash flow
$1.57B
Per share
EPS
$0.6
Free cash flow per share
$1.08
Book value per share
$12.68
Revenue per share
$9.27
TBVPS
$9.6
Balance sheet
Total assets
$33.6B
Total liabilities
$15.12B
Debt
$9.05B
Equity
$18.23B
Working capital
$1.32B
Liquidity
Debt to equity
0.5
Current ratio
1.29
Quick ratio
0.56
Net debt/EBITDA
2.94
Margins
EBITDA margin
21.9%
Gross margin
69.5%
Net margin
6.8%
Operating margin
13.6%
Efficiency
Return on assets
2.6%
Return on equity
4.8%
Return on invested capital
9.9%
Return on capital employed
6.1%
Return on sales
13.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BSX stock price

How has the Boston Scientific stock price performed over time
Intraday
-0.69%
1 week
1.32%
1 month
6.33%
1 year
36.39%
YTD
15.84%
QTD
-0.91%

Financial performance

How have Boston Scientific's revenue and profit performed over time
Revenue
$13.4B
Gross profit
$9.31B
Operating income
$1.82B
Net income
$911M
Gross margin
69.5%
Net margin
6.8%
Boston Scientific's operating income has increased by 25% YoY and by 5% from the previous quarter
BSX's operating margin is up by 14% year-on-year and by 2.3% since the previous quarter
Boston Scientific's gross profit has increased by 10% YoY and by 3.4% QoQ
The revenue has increased by 9% YoY and by 2.7% from the previous quarter

Growth

What is Boston Scientific's growth rate over time

Valuation

What is Boston Scientific stock price valuation
BSX P/E details
P/E
89.33
P/B
4.23
P/S
5.78
EV/EBIT
49.16
EV/EBITDA
29.7
EV/Sales
6.5
The P/E is 29% above the 5-year quarterly average of 69.3 but 4% below the last 4 quarters average of 93.1
The EPS has increased by 5% YoY
The stock's price to book (P/B) is 11% more than its last 4 quarters average of 3.8
The equity has grown by 6% YoY and by 2.1% from the previous quarter
BSX's P/S is 11% above its 5-year quarterly average of 5.2 and 11% above its last 4 quarters average of 5.2
The revenue has increased by 9% YoY and by 2.7% from the previous quarter

Efficiency

How efficient is Boston Scientific business performance
BSX's ROIC is up by 5% YoY and by 4.2% from the previous quarter
The ROS has increased by 2.3% from the previous quarter
The return on equity has declined by 2% year-on-year

Dividends

What is BSX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BSX.

Financial health

How did Boston Scientific financials performed over time
Boston Scientific's total assets is 122% more than its total liabilities
BSX's quick ratio is down by 14% since the previous quarter
BSX's current ratio is down by 8% since the previous quarter
Boston Scientific's debt is 50% lower than its equity
The equity has grown by 6% YoY and by 2.1% from the previous quarter
Boston Scientific's debt to equity has decreased by 3.8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.